Form D · Other Health Care
SEMPRUS BIOSCIENCES CORP
Cambridge, MA · CIK 0001448152
Offering snapshot reported Dec 22, 2010 · SEC filing
- Reported sold
- $9M Offering amount: $18.8M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 9, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 22, 2010 | Initial | $9,004,031 | No comparison | 5 | SEC filing |
| Dec 22, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 14, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-152404
Source: Form D, filed Dec 22, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Simeon George | Director |
| Robert Langer | Director |
| Christopher Loose | Executive |
| David L. Lucchino | Director, Executive |
| Scott Rocklage | Director |
| Purnesh Seegopaul | Director |
| John Sullivan | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
One Kendall Square Building 1400, First Floor
Cambridge, MA, 02139
Cambridge, MA, 02139